Ever Supreme Bio Technology Co., Ltd
6712.TWO
Price:
$169
Market Cap:
$14.80B
Ever Supreme Bio Technology Co., Ltd engages in the research, development, and manufacture of drug products related to human mesenchymal stem cells and immune cells. Its products include UMC01, a drug candidate in Phase I clinical trials for the treatment of myocardial infarction and stroke; ADCV01, a drug candidate in Phase II clinical trials for the treatment of malignant brain tumor; CAR001, a chimeric antigen receptor immune cells product; and bone-marrow stem cells (BMSC), used to treat chronic stroke, degenerative osteoarthritis, and spinal cord injuries. The company was incorporated in 2016 and is based in Taichung, Taiwan.
Industry
Biotechnology
IPO Date
2018-10-26
Stock Exchange
TWO
Ticker
6712.TWO
PE Ratio
[28.74]
ROE
[28.28%]
Current Ratio
[1.41]
Dividend Yield
[2.75%]
Enterprise Value
[14.71B]
Dividend History
The ROE as of December 2025 (TTM) for Ever Supreme Bio Technology Co., Ltd (6712.TWO) is 28.28%
According to Ever Supreme Bio Technology Co., Ltd’s latest financial reports and current stock price. The company's current ROE is 28.28%. This represents a change of 306.14% compared to the average of 6.96% of the last 4 quarters.
Ever Supreme Bio Technology Co., Ltd (6712.TWO) Historical ROE (quarterly & annually)
How has 6712.TWO ROE performed in the past?
The mean historical ROE of Ever Supreme Bio Technology Co., Ltd over the last ten years is 9.26%. The current 28.28% ROE has changed 205.28% with respect to the historical average. Over the past ten years (40 quarters), 6712.TWO's ROE was at its highest in in the September 2023 quarter at 15.76%. The ROE was at its lowest in in the September 2024 quarter at 1.17%.
Average
9.26%
Median
15.34%
Minimum
-13.68%
Maximum
29.27%
Ever Supreme Bio Technology Co., Ltd (6712.TWO) ROE by Quarter and Year
Discovering the peaks and valleys of Ever Supreme Bio Technology Co., Ltd ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 161.33%
Maximum Annual ROE = 29.27%
Minimum Annual Increase = -242.34%
Minimum Annual ROE = -13.68%
| Year | ROE | Change |
|---|---|---|
| 2024 | 20.47% | -30.07% |
| 2023 | 29.27% | 161.33% |
| 2022 | 11.20% | -42.49% |
| 2021 | 19.48% | -242.34% |
| 2020 | -13.68% | 22.85% |
Ever Supreme Bio Technology Co., Ltd (6712.TWO) Average ROE
How has 6712.TWO ROE performed in the past?
The current ROE of Ever Supreme Bio Technology Co., Ltd (6712.TWO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
20.31%
5-year avg
13.35%
10-year avg
9.26%
Ever Supreme Bio Technology Co., Ltd (6712.TWO) ROE vs. Peers
How is 6712.TWO’s ROE compared to its peers?
Ever Supreme Bio Technology Co., Ltd’s ROE is greater than Tanvex BioPharma, Inc. (-45.02%), less than Excelsior Medical Co., Ltd. (9.09%), less than ScinoPharm Taiwan, Ltd. (1.95%), greater than Medigen Vaccine Biologics Corporation (-3.74%), less than PharmaEngine, Inc. (33.38%), less than YungShin Global Holding Corporation (12.84%), less than United Orthopedic Corporation (12.99%), greater than AP Biosciences Inc (-25.56%), greater than Acepodia, Inc. (-11.14%), less than Visco Vision Inc. (19.17%),
| Company | ROE | Market cap |
|---|---|---|
| -45.02% | $14.96B | |
| 9.09% | $14.00B | |
| 1.95% | $13.68B | |
| -3.74% | $13.30B | |
| 33.38% | $10.43B | |
| 12.84% | $15.02B | |
| 12.99% | $11.57B | |
| -25.56% | $12.00B | |
| -11.14% | $8.66B | |
| 19.17% | $10.93B |
Build a custom stock screener for Ever Supreme Bio Technology Co., Ltd (6712.TWO) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ever Supreme Bio Technology Co., Ltd using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Ever Supreme Bio Technology Co., Ltd (6712.TWO) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Ever Supreme Bio Technology Co., Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Ever Supreme Bio Technology Co., Ltd's ROE?
How is the ROE calculated for Ever Supreme Bio Technology Co., Ltd (6712.TWO)?
What is the highest ROE for Ever Supreme Bio Technology Co., Ltd (6712.TWO)?
What is the 3-year average ROE for Ever Supreme Bio Technology Co., Ltd (6712.TWO)?
What is the 5-year average ROE for Ever Supreme Bio Technology Co., Ltd (6712.TWO)?
How does the current ROE for Ever Supreme Bio Technology Co., Ltd (6712.TWO) compare to its historical average?